Business Context and Reporting Period
This Form 8-K reports on the 2015 Annual Meeting of Stockholders held by Vital Therapies, Inc. on November 17, 2015. The filing details the outcomes of shareholder votes regarding director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Approximately 76% of the 24,145,680 outstanding shares were represented at the meeting (18,379,608 shares). The following matters were voted upon:
- Election of Class I Directors: All three nominees were elected to serve until the 2018 annual meeting.
- Philip M. Croxford: 11,766,569 votes for, 154,358 withheld.
- Randolph C. Steer, M.D., Ph.D.: 11,765,719 votes for, 155,208 withheld.
- Terence E. Winters, Ph.D.: 11,766,635 votes for, 154,292 withheld.
- Ratification of Auditor: The appointment of PricewaterhouseCoopers LLP for the fiscal year ending December 31, 2015, was ratified.
- For: 18,338,468
- Against: 26,523
- Abstain: 14,617
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the official appointment of PricewaterhouseCoopers LLP as the independent auditor for the 2015 fiscal year.
- Confirm the tenure of the newly elected Class I directors (Philip M. Croxford, Randolph C. Steer, and Terence E. Winters) extending through the 2018 annual meeting.
- Note the high level of shareholder participation, with 76% of outstanding shares represented at the meeting.